An **Anti-dsDNA Antibody (IFA) Serum** test utilizes Indirect Immunofluorescence Assay (IFA) technology to detect autoantibodies targeting double-stranded DNA. This specialized method often employs *Crithidia luciliae* as a substrate, providing a highly specific substrate (the kinetoplast) to definitively confirm a **Systemic Lupus Erythematosus (SLE)** diagnosis.

By visualizing the fluorescent staining patterns under a microscope, clinicians can accurately differentiate lupus from other autoimmune conditions. Because positive IFA results correlate strongly with active **lupus nephritis**, this serum test serves as a critical biomarker for monitoring disease severity, predicting renal flares, and guiding clinical immunosuppressive therapies.

An ANCA by IFA reflex MPO/PR3 serum diagnostic test is a highly specific method used for diagnosing and monitoring ANCA-associated vasculitis (AAV), a rare group of autoimmune diseases that affect small to medium blood vessels.

The test begins with an indirect immunofluorescence assay (IFA) on human serum. This initial step determines the presence of antineutrophil cytoplasmic antibodies (ANCA) and characterizes their staining pattern, typically as either cytoplasmic (c-ANCA) or perinuclear (p-ANCA). If the IFA test yields a positive result, a reflex test is automatically performed. This reflex step uses enzyme-linked immunosorbent assay (ELISA) technology to precisely measure the concentration of antibodies specific for myeloperoxidase (MPO) and proteinase 3 (PR3).

This combined diagnostic approach provides comprehensive data, enabling healthcare providers to accurately identify the specific ANCA-associated vasculitis type, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), or eosinophilic granulomatosis with polyangiitis (EGPA), and initiate appropriate treatment strategies.

The Allergy Panel-Others Adult (Comprehensive) Panel (By IMMUNO-EIA) is an advanced blood test designed to evaluate specific IgE-mediated responses to a broad spectrum of miscellaneous and unconventional allergens. Utilizing high-precision Enzyme Immunoassay (EIA) technology, this panel measures antibody concentrations triggered by environmental and occupational factors not covered in standard panels.

It typically evaluates parameters such as latex, common indoor and outdoor molds, occupational chemicals, and regional tree or grass pollens. Essential for adults presenting with unexplained respiratory issues, hives, or systemic reactions, this comprehensive panel helps clinicians pinpoint specific hidden triggers to formulate effective, tailored allergen-avoidance plans.

The Allergy - Vegetarian Panel (By IMMUNO-EIA) is a focused diagnostic blood test designed to identify specific IgE-mediated allergic reactions to common vegetarian food sources. This comprehensive panel utilizes Enzyme Immunoassay (EIA) technology to measure the concentration of allergen-specific antibodies in response to a range of plant-based proteins.

The panel typically screens for sensitivities to key vegetarian staples, such as soy, wheat (gluten), peanuts, various tree nuts, legumes, and seeds. It is particularly valuable for individuals following a vegetarian or vegan diet who experience symptoms like hives, digestive distress, or respiratory issues after meals. By precisely pinpointing the plant-based triggers, this diagnostic tool enables healthcare providers to create targeted dietary management plans, effectively distinguishing true food allergies from other food intolerances to ensure nutritional safety.

The Allergy - Non-vegetarian Panel (By IMMUNO-EIA) is a specialized blood test designed to identify specific IgE-mediated allergic reactions to various meats, poultry, and seafood. Utilizing advanced Enzyme Immunoassay (EIA) technology, this comprehensive panel measures the concentration of antibodies triggered by consuming non-vegetarian foods.

The test typically screens for individual sensitivities to common proteins found in chicken, mutton, beef, pork, fish, and shellfish. It is vital for individuals experiencing hives, gastrointestinal distress, or anaphylaxis after meals. This accurate diagnostic tool helps clinicians distinguish true food allergies from food intolerances to guide safe dietary management.

This rapid, automated DNA test detects active Tuberculosis (M.Tb) and checks for resistance to the two most critical first-line TB medications: Rifampicin and Isoniazid.

Using advanced CBNAAT (GeneXpert) technology, the test analyzes samples (like sputum, fluid, or tissue) to identify bacterial DNA within hours. Simultaneously, it maps genetic mutations responsible for drug resistance.

By confirming whether the infection is standard TB or drug-resistant TB (such as MDR-TB), this test prevents critical treatment delays. It allows doctors to bypass weeks of traditional lab cultures and immediately prescribe the most effective, lifesaving antibiotic regimen.

This is an advanced, rapid molecular test used to detect tuberculosis (TB) or other similar infections directly from a small piece of body tissue (obtained via a biopsy or minor surgical procedure).

It uses a technology called CBNAAT (Cartridge-Based Nucleic Acid Amplification Test), famously known as the GeneXpert test. Instead of waiting weeks to grow bacteria in a lab, this machine looks directly for the genetic material (DNA) of the bacteria, giving highly accurate results in just a few hours.

When is a tissue sample used?
While TB is most common in the lungs, it can also infect other parts of the body—this is known as Extrapulmonary TB. Doctors recommend this test on tissue samples when they suspect TB in areas like:

Lymph nodes (swellings in the neck, armpits, etc.)

Skin or bone tissue

Gastrointestinal tissue

Other internal organs

What does the test detect?
The test checks for three crucial things simultaneously:

M.Tb (Mycobacterium tuberculosis): The specific bacteria that causes traditional Tuberculosis.

NTM (Nontuberculous Mycobacteria): A different family of environmental bacteria. NTM can cause tissue infections that look exactly like TB but require completely different antibiotics to cure.

Rifampicin Resistance: It instantly checks if the bacteria are resistant to Rifampicin (a major first-line TB medicine). This tells your doctor immediately if a standard treatment will work or if a specialized, stronger regimen is required.

This is a modern, rapid molecular test used to detect tuberculosis (TB) from a cough sample (sputum). It uses an advanced technology called CBNAAT (Cartridge-Based Nucleic Acid Amplification Test), commonly known as the GeneXpert test.

Instead of just looking for the bacteria under a microscope, this test looks directly for the DNA of the bacteria, making it incredibly fast and accurate.

What does the test detect?
The test checks for three major things at the same time:

M.Tb (Mycobacterium tuberculosis): The bacteria responsible for causing active Tuberculosis.

NTM (Nontuberculous Mycobacteria): A different family of environmental bacteria that can mimic TB symptoms but requires completely different treatment.

Rifampicin Resistance: It checks if the TB bacteria are resistant to Rifampicin, one of the main medicines used to cure TB. This helps doctors know immediately if a stronger treatment plan is needed.

Why is this test preferred over routine tests?
Speed: Gives accurate results within a few hours, whereas traditional bacterial cultures can take weeks.

High Accuracy: It can find TB bacteria even if there is only a tiny amount present in the sputum sample (which routine microscopy often misses).

Clear Distinction: It tells the doctor exactly whether you have standard TB or an NTM infection, preventing the wrong medicine from being prescribed.

An AFB-M.Tb Detection (M.Tb/NTM Detection) by CBNAAT on Ascitic Fluid is a targeted molecular diagnostic test designed to identify tuberculosis infections within the peritoneal (abdominal) cavity.

This specific test is a frontline tool for diagnosing Tuberculous Peritonitis (abdominal TB). What makes this panel unique is its dual capability: it not only checks for the classic Mycobacterium tuberculosis complex but also differentiates it from NTM (Non-Tuberculous Mycobacteria), which require completely different clinical treatment strategies.

1. Breaking Down the Terminology
M.Tb: Mycobacterium tuberculosis, the primary pathogen responsible for classic tuberculosis.

NTM: Non-Tuberculous Mycobacteria (also known as atypical mycobacteria). These are environmental organisms that can mimic TB symptoms and presentation but do not respond to standard anti-TB medications.

CBNAAT: Cartridge-Based Nucleic Acid Amplification Test. It uses automated, rapid Polymerase Chain Reaction (PCR) technology to detect the specific DNA signatures of these organisms.

Ascitic Fluid: The fluid that builds up in the peritoneal cavity of the abdomen (a condition called ascites) due to inflammation, infection, or other medical conditions.

An AFB-Xpert Panel (MTB/RIF Detection & AFB Culture) for extrapulmonary samples is a comprehensive diagnostic profile. It combines two different testing methodologies—molecular testing (CBNAAT/GeneXpert) and traditional microbiology (AFB Culture)—to provide the highest possible accuracy when identifying tuberculosis outside of the lungs.

By pairing these two tests, clinicians get the speed of genetic testing alongside the definitive accuracy of a live culture.

1. Component 1: Rapid Molecular Testing (MTB/RIF by CBNAAT)
The first phase of the panel uses DNA amplification technology to analyze non-lung samples (such as lymph node aspirates, cerebrospinal fluid (CSF), pleural fluid, or tissue biopsies).

M.Tb Detection: It targets specific DNA sequences of the Mycobacterium tuberculosis complex, offering a rapid "yes/no" result.

Rifampicin Resistance: It analyzes the rpoB gene of the bacteria. If mutations are found, it indicates resistance to Rifampicin. This allows doctors to flag suspected Multi-Drug Resistant TB (MDR-TB) within just 2 hours.

An AFB-Xpert Panel (M.Tb Detection & Rifampicin Resistance) by CBNAAT for pulmonary samples is a highly efficient, automated molecular test. It serves as the frontline tool for rapidly diagnosing Tuberculosis (TB) in the lungs and checking if the bacteria are resistant to one of the most powerful first-line TB medications, Rifampicin.

Unlike extra-pulmonary testing, which deals with fluids and tissues from other organs, pulmonary testing specifically evaluates secretions from the respiratory tract.

1. What does the name mean?
AFB: Acid-Fast Bacilli (the class of bacteria to which Mycobacterium tuberculosis belongs).

CBNAAT: Cartridge-Based Nucleic Acid Amplification Test (commonly known as the GeneXpert test). It uses PCR technology to multiply and detect the DNA of the TB bacteria.

Pulmonary samples: Samples originating from the lungs and respiratory airways.

2. Common Pulmonary Sample Types
Because pulmonary TB directly affects the lungs, the sample types are respiratory secretions:

Sputum (Spontaneous): The thick mucus coughed up deeply from the lungs. This is the most common sample type.

Induced Sputum: If a patient cannot cough up sputum naturally, they inhale a sterile saline mist to help loosen secretions.

Bronchoalveolar Lavage (BAL): Fluid collected during a bronchoscopy, where a doctor passes a small scope into the lungs and flushes the area with saline. This is often used for complex or hard-to-diagnose cases.

Gastric Aspirate/Lavage: Commonly used in young children who cannot expectorate (spit out) sputum and instead swallow their respiratory secretions overnight.

An AFB-DNA (TB-PCR) Detection by Real-Time PCR with Reflex to Rifampicin Resistance by Ultra CBNAAT on Sputum is a premier, ultra-sensitive molecular test for diagnosing Pulmonary Tuberculosis (TB).

While traditional microscopic smears look for the physical bacterium under a lens, this advanced panel directly extracts and copies the genetic blueprint (DNA) of the Mycobacterium tuberculosis complex. It stands as a vital frontline diagnostic tool because it rapidly answers two clinical questions directly from a sputum sample: Is the patient infected with TB? and if so, Will standard first-line antibiotics work against it?

Deconstructing the Test Terminology
AFB-DNA (TB-PCR) by RTPCR: The laboratory uses Real-Time Polymerase Chain Reaction to replicate specific genetic sequences unique to TB. Because it amplifies target DNA millions of times, it can detect the presence of the bacteria even if the patient has a very low bacterial load (paucibacillary sputum), which a standard microscope smear would completely miss.

Reflex to Ultra CBNAAT: "Reflexing" means the laboratory automation software automatically launches a secondary, deeper test only if the initial PCR screen detects TB DNA. The patient does not need to return to give a second sample.

Ultra CBNAAT (Cartridge-Based Nucleic Acid Amplification Test): This refers specifically to the newer GeneXpert MTB/RIF Ultra technology. The "Ultra" cartridge features an increased sample chamber volume and nested PCR technology, providing unmatched sensitivity.

Rifampicin Resistance: Rifampicin is a cornerstone drug in standard anti-tubercular therapy. The Ultra assay maps the bacterial rpoB gene to check for mutations that make the bacteria immune to Rifampicin. Resistance to this drug is a critical marker for Multidrug-Resistant Tuberculosis (MDR-TB).